These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2797378)

  • 1. SSPE-epidemiology and measles vaccination: our cases.
    Vucenović V; Vranjesević D
    Neurologija; 1989; 38(1):23-31. PubMed ID: 2797378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
    Enders-Ruckle G
    Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subacute sclerosing panencephalitis in Bulgaria (1978-2002).
    Bojinova V; Dimova P; Belopitova L; Mihailov A; Gatcheva N; Mihneva Z; Todorova M
    Neuroepidemiology; 2004; 23(5):254-7. PubMed ID: 15316253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.
    Modlin JF; Jabbour JT; Witte JJ; Halsey NA
    Pediatrics; 1977 Apr; 59(4):505-12. PubMed ID: 850592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
    Zilber N; Rannon L; Alter M; Kahana E
    Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subacute sclerosing panencephalitis in Wales.
    Sussman J; Compston DA
    Q J Med; 1994 Jan; 87(1):23-34. PubMed ID: 8140214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
    J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era.
    Sonia M; Lalit D; Shobha B; Sheffali G; Amandeep S; Veena K; Madhuri B
    J Commun Dis; 2009 Sep; 41(3):161-7. PubMed ID: 22010482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.
    Miller C; Andrews N; Rush M; Munro H; Jin L; Miller E
    Arch Dis Child; 2004 Dec; 89(12):1145-8. PubMed ID: 15557053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiological study of subacute sclerosing panencephalitis in Japan, 1976.
    Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Sato T; Isomura S; Ueda S; Kitamura I; Kaji M
    Biken J; 1978 Mar; 21(A):9-14. PubMed ID: 666722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the effect of measles vaccination on the epidemiology of SSPE.
    Campbell H; Andrews N; Brown KE; Miller E
    Int J Epidemiol; 2007 Dec; 36(6):1334-48. PubMed ID: 18037676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subacute sclerosing panencephalitis (SSPE) in Poland 1984-1986. Stage III of epidemiologic studies].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska B; Kulczycki J; Gut W
    Przegl Epidemiol; 1988; 42(3):205-10. PubMed ID: 3254552
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of the correlation between measles and subacute sclerosis panencephalitis (SSPE) before and after introduction of vaccination in Poland].
    Gut W; Naruszewicz-Lesiuk D
    Przegl Epidemiol; 1992; 46(4):295-301. PubMed ID: 1305779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of clinical course of subacute sclerosing panencephalitis: experience at the Children's Hospital, Lahore.
    Malik MA; Saeed M; Qureshi AU; Ahmed N; Akram M
    J Coll Physicians Surg Pak; 2010 Oct; 20(10):671-4. PubMed ID: 20943110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological aspects of SSPE].
    Nihei K
    Nihon Rinsho; 2007 Aug; 65(8):1460-5. PubMed ID: 17695284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subacute sclerosing panencephalitis: fulminant form].
    Grippo J; Cáceres L; Asís A; Grippo T; Ruprecht B; López M
    Rev Neurol; 2003 Mar 16-31; 36(6):536-9. PubMed ID: 12652417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles vaccination and risk of SSPE.
    Agarwal RK
    Indian Pediatr; 1999 Mar; 36(3):317. PubMed ID: 10713848
    [No Abstract]   [Full Text] [Related]  

  • 18. Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated.
    Wendorf KA; Winter K; Zipprich J; Schechter R; Hacker JK; Preas C; Cherry JD; Glaser C; Harriman K
    Clin Infect Dis; 2017 Jul; 65(2):226-232. PubMed ID: 28387784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further epidemiological investigations on subacute sclerosing panencephalitis (SSPE) in Romania.
    Cernescu C; Milea S
    Virologie; 1980; 31(3):173-82. PubMed ID: 6254241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.
    Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Fukuyama Y; Sato T; Isomura S; Ueda S; Kitamura I
    Int J Epidemiol; 1989 Sep; 18(3):684-9. PubMed ID: 2807674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.